LabGenomics (Korea) Performance
084650 Stock | KRW 2,770 20.00 0.73% |
The company secures a Beta (Market Risk) of 0.31, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, LabGenomics' returns are expected to increase less than the market. However, during the bear market, the loss of holding LabGenomics is expected to be smaller as well. LabGenomics has an expected return of -0.46%. Please make sure to verify LabGenomics Co market risk adjusted performance, coefficient of variation, jensen alpha, as well as the relationship between the mean deviation and standard deviation , to decide if LabGenomics performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days LabGenomics Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in June 2024. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Total Cashflows From Investing Activities | -26.1 B |
LabGenomics |
LabGenomics Relative Risk vs. Return Landscape
If you would invest 370,000 in LabGenomics Co on February 6, 2024 and sell it today you would lose (93,000) from holding LabGenomics Co or give up 25.14% of portfolio value over 90 days. LabGenomics Co is generating negative expected returns and assumes 2.0579% volatility on return distribution over the 90 days horizon. Simply put, 18% of stocks are less volatile than LabGenomics, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
Risk |
LabGenomics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for LabGenomics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as LabGenomics Co, and traders can use it to determine the average amount a LabGenomics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.2238
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | 084650 |
Estimated Market Risk
2.06 actual daily | 18 82% of assets are more volatile |
Expected Return
-0.46 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.22 actual daily | 0 Most of other assets perform better |
Based on monthly moving average LabGenomics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of LabGenomics by adding LabGenomics to a well-diversified portfolio.
LabGenomics Fundamentals Growth
LabGenomics Stock prices reflect investors' perceptions of the future prospects and financial health of LabGenomics, and LabGenomics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on LabGenomics Stock performance.
Return On Equity | 42.82 | |||
Return On Asset | 0.46 | |||
Profit Margin | 0.38 % | |||
Operating Margin | 0.48 % | |||
Current Valuation | 356.77 B | |||
Shares Outstanding | 9.08 M | |||
Price To Sales | 2.02 X | |||
Revenue | 202.41 B | |||
EBITDA | 70.81 B | |||
Cash And Equivalents | 70.53 B | |||
Total Debt | 4.4 B | |||
Cash Flow From Operations | 66.08 B | |||
Total Asset | 204.29 B | |||
About LabGenomics Performance
To evaluate LabGenomics Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when LabGenomics generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare LabGenomics Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand LabGenomics market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents LabGenomics's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.Things to note about LabGenomics performance evaluation
Checking the ongoing alerts about LabGenomics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for LabGenomics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.LabGenomics generated a negative expected return over the last 90 days | |
About 13.0% of the company shares are owned by insiders or employees |
- Analyzing LabGenomics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether LabGenomics' stock is overvalued or undervalued compared to its peers.
- Examining LabGenomics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating LabGenomics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of LabGenomics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of LabGenomics' stock. These opinions can provide insight into LabGenomics' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in LabGenomics Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the LabGenomics information on this page should be used as a complementary analysis to other LabGenomics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Complementary Tools for LabGenomics Stock analysis
When running LabGenomics' price analysis, check to measure LabGenomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LabGenomics is operating at the current time. Most of LabGenomics' value examination focuses on studying past and present price action to predict the probability of LabGenomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LabGenomics' price. Additionally, you may evaluate how the addition of LabGenomics to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |